Triple vs Dual Inhaler Therapy and Asthma Outcomes in Moderate to Severe Asthma

Among children (aged 6 to 18 years) and adults with moderate to severe asthma, triple therapy, compared with dual therapy, was significantly associated with fewer severe asthma exacerbations and modest improvements in asthma control without significant differences in quality of life or mortality.